1 |
Ryu, S. H., Suh, P. G., Cho, K. S., Lee, K. Y. and Rhee, S. G. 1987. Bovine brain cytosol contains three immunologically distinct forms of inositolphospholipid-specific phospholipase c. Proc. Natl. Acad. Sci. USA. 84, 6649-6653.
DOI
|
2 |
Schade, A., Walliser, C., Wist, M., Haas, J., Vatter, P., Kraus, J. M., Filingeri, D., Havenith, G., Kestler, H. A. and Milner, J. D., et al. 2016. Cool-temperature-mediated activation of phospholipase c-gamma2 in the human hereditary disease plaid. Cell Signal. 28, 1237-1251.
DOI
|
3 |
Serrano, C. J., Graham, L., Debell, K., Rawat, R., Veri, M. C., Bonvini, E., Rellahan, B. L. and Reischl, I. G. 2005. A new tyrosine phosphorylation site in plc gamma 1: The role of tyrosine 775 in immune receptor signaling. J. Immunol. 174, 6233-6237.
DOI
|
4 |
Sierksma, A., Lu, A., Mancuso, R., Fattorelli, N., Thrupp, N., Salta, E., Zoco, J., Blum, D., Buee, L. and De Strooper, B., et al. 2020. Novel alzheimer risk genes determine the microglia response to amyloid-beta but not to tau pathology. EMBO Mol. Med. 12, e10606.
|
5 |
Bae, J. H., Lew, E. D., Yuzawa, S., Tome, F., Lax, I. and Schlessinger, J. 2009. The selectivity of receptor tyrosine kinase signaling is controlled by a secondary sh2 domain binding site. Cell 138, 514-524.
DOI
|
6 |
Behjati, S., Tarpey, P. S., Sheldon, H., Martincorena, I., Van Loo, P., Gundem, G., Wedge, D. C., Ramakrishna, M., Cooke, S. L. and Pillay, N., et al. 2014. Recurrent ptprb and plcg1 mutations in angiosarcoma. Nat. Genet. 46, 376-379.
DOI
|
7 |
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N. and Bourne, P. E. 2000. The protein data bank. Nucleic Acids Res. 28, 235-242.
DOI
|
8 |
Bunney, T. D., Esposito, D., Mas-Droux, C., Lamber, E., Baxendale, R. W., Martins, M., Cole, A., Svergun, D., Driscoll, P. C. and Katan, M. 2012. Structural and functional integration of the plcgamma interaction domains critical for regulatory mechanisms and signaling deregulation. Structure 20, 2062-2075.
DOI
|
9 |
Streb, H., Irvine, R. F., Berridge, M. J. and Schulz, I. 1983. Release of ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 306, 67-69.
DOI
|
10 |
Sims, R., Van Der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., Raybould, R. and Bis, J. C., et al. 2017. Rare coding variants in plcg2, abi3, and trem2 implicate microglial-mediated innate immunity in alzheimer's disease. Nat. Genet. 49, 1373-1384.
DOI
|
11 |
Suh, P. G., Park, J. I., Manzoli, L., Cocco, L., Peak, J. C., Katan, M., Fukami, K., Kataoka, T., Yun, S. and Ryu, S. H. 2008. Multiple roles of phosphoinositide-specific phospholipase c isozymes. BMB Rep. 41, 415-434.
DOI
|
12 |
Suh, P. G., Ryu, S. H., Moon, K. H., Suh, H. W. and Rhee, S. G. 1988. Cloning and sequence of multiple forms of phospholipase c. Cell 54, 161-169.
DOI
|
13 |
Takai, Y., Kishimoto, A., Iwasa, Y., Kawahara, Y., Mori, T. and Nishizuka, Y. 1979. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J. Biol. Chem. 254, 3692-3695.
DOI
|
14 |
Takalo, M., Wittrahm, R., Wefers, B., Parhizkar, S., Jokivarsi, K., Kuulasmaa, T., Makinen, P., Martiskainen, H., Wurst, W. and Xiang, X., et al. 2020. The alzheimer's disease-associated protective -p522r variant promotes beneficial microglial functions. Mol. Neurodegener. 15, 52.
DOI
|
15 |
Takenawa, T. and Nagai, Y. 1981. Purification of phosphatidylinositol-specific phospholipase c from rat liver. J. Biol. Chem. 256, 6769-6775.
DOI
|
16 |
Ellis, M. V., James, S. R., Perisic, O., Downes, C. P., Williams, R. L. and Katan, M. 1998. Catalytic domain of phosphoinositide-specific phospholipase c (plc). Mutational analysis of residues within the active site and hydrophobic ridge of plcdelta1. J. Biol. Chem. 273, 11650-11659.
DOI
|
17 |
Cockcroft, S. and Gomperts, B. D. 1985. Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesterase. Nature 314, 534-536.
DOI
|
18 |
Dawson, R. M. 1959. Studies on the enzymic hydrolysis of monophosphoinositide by phospholipase preparations from p. Notatum and ox pancreas. Biochim. Biophys. Acta. 33, 68-77.
DOI
|
19 |
De Lange, K. M., Moutsianas, L., Lee, J. C., Lamb, C. A., Luo, Y., Kennedy, N. A., Jostins, L., Rice, D. L., Gutierrez-Achury, J. and Ji, S. G., et al. 2017. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256-261.
DOI
|
20 |
Falasca, M., Logan, S. K., Lehto, V. P., Baccante, G., Lemmon, M. A. and Schlessinger, J. 1998. Activation of phospholipase c gamma by pi 3-kinase-induced ph domain-mediated membrane targeting. EMBO J. 17, 414-422.
DOI
|
21 |
Follo, M. Y., Pellagatti, A., Armstrong, R. N., Ratti, S., Mongiorgi, S., De Fanti, S., Bochicchio, M. T., Russo, D., Gobbi, M. and Miglino, M., et al. 2019. Response of high-risk mds to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes. Leukemia 33, 2276-2290.
DOI
|
22 |
Ftouhi-Paquin, N., Alda, M., Grof, P., Chretien, N., Rouleau, G. and Turecki, G. 2001. Identification of three polymorphisms in the translated region of plc-gamma1 and their investigation in lithium responsive bipolar disorder. Am. J. Med. Genet. 105, 301-305.
DOI
|
23 |
Vaque, J. P., Gomez-Lopez, G., Monsalvez, V., Varela, I., Martinez, N., Perez, C., Dominguez, O., Grana, O., Rodriguez-Peralto, J. L. and Rodriguez-Pinilla, S. M., et al. 2014. Plcg1 mutations in cutaneous t-cell lymphomas. Blood 123, 2034-2043.
DOI
|
24 |
Turecki, G., Grof, P., Cavazzoni, P., Duffy, A., Grof, E., Ahrens, B., Berghofer, A., Muller-Oerlinghausen, B., Dvorakova, M. and Libigerova, E., et al. 1998. Evidence for a role of phospholipase c-gamma1 in the pathogenesis of bipolar disorder. Mol. Psychiatry 3, 534-538.
DOI
|
25 |
Vallois, D., Dobay, M. P., Morin, R. D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Fataccioli, V., Bisig, B. and Roberti, A., et al. 2016. Activating mutations in genes related to tcr signaling in angioimmunoblastic and other follicular helper t-cell-derived lymphomas. Blood 128, 1490-1502.
|
26 |
Van Der Lee, S. J., Conway, O. J., Jansen, I., Carrasquillo, M. M., Kleineidam, L., Van Den Akker, E., Hernandez, I., Van Eijk, K. R., Stringa, N. and Chen, J. A., et al. 2019. A nonsynonymous mutation in plcg2 reduces the risk of alzheimer's disease, dementia with lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta. Neuropathol. 138, 237-250.
DOI
|
27 |
Walliser, C., Wist, M., Hermkes, E., Zhou, Y., Schade, A., Haas, J., Deinzer, J., Desire, L., Li, S. S. C. and Stilgenbauer, S., et al. 2018. Functional characterization of phospholipase c-gamma2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder. Oncotarget 9, 34357-34378.
DOI
|
28 |
Wang, D., Feng, J., Wen, R., Marine, J. C., Sangster, M. Y., Parganas, E., Hoffmeyer, A., Jackson, C. W., Cleveland, J. L. and Murray, P. J., et al. 2000. Phospholipase cgamma2 is essential in the functions of b cell and several fc receptors. Immunity 13, 25-35.
DOI
|
29 |
Gbadegesin, R. A., Adeyemo, A., Webb, N. J., Greenbaum, L. A., Abeyagunawardena, A., Thalgahagoda, S., Kale, A., Gipson, D., Srivastava, T. and Lin, J. J., et al. 2015. Hla-dqa1 and plcg2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1701-1710.
DOI
|
30 |
Fu, G., Chen, Y., Yu, M., Podd, A., Schuman, J., He, Y., Di, L., Yassai, M., Haribhai, D. and North, P. E., et al. 2010. Phospholipase c{gamma}1 is essential for t cell development, activation, and tolerance. J. Exp. Med. 207, 309-318.
DOI
|
31 |
Gellatly, S. A., Kalujnaia, S. and Cramb, G. 2012. Cloning, tissue distribution and sub-cellular localisation of phospholipase c x-domain containing protein (plcxd) isoforms. Biochem. Biophys. Res. Commun. 424, 651-656.
DOI
|
32 |
Hajicek, N., Charpentier, T. H., Rush, J. R., Harden, T. K. and Sondek, J. 2013. Autoinhibition and phosphorylation-induced activation of phospholipase c-gamma isozymes. Biochemistry 52, 4810-4819.
DOI
|
33 |
Hajicek, N., Keith, N. C., Siraliev-Perez, E., Temple, B. R., Huang, W., Zhang, Q., Harden, T. K. and Sondek, J. 2019. Structural basis for the activation of plc-gamma isozymes by phosphorylation and cancer-associated mutations. Elife 8.
|
34 |
Harlan, J. E., Hajduk, P. J., Yoon, H. S. and Fesik, S. W. 1994. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature 371, 168-170.
DOI
|
35 |
Hokin, L. E. and Hokin, M. R. 1953. The incorporation of 32p into the nucleotides of ribonucleic acid in pigeon pancreas slices. Biochim. Biophys. Acta. 11, 591-592.
DOI
|
36 |
Ichise, H., Ichise, T. and Yoshida, N. 2016. Phospholipase cgamma2 is required for luminal expansion of the epididymal duct during postnatal development in mice. PLoS One 11, e0150521.
DOI
|
37 |
Zhou, Q., Lee, G. S., Brady, J., Datta, S., Katan, M., Sheikh, A., Martins, M. S., Bunney, T. D., Santich, B. H. and Moir, S., et al. 2012. A hypermorphic missense mutation in plcg2, encoding phospholipase cgamma2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. Am. J. Hum. Genet. 91, 713-720.
DOI
|
38 |
Woyach, J. A., Furman, R. R., Liu, T. M., Ozer, H. G., Zapatka, M., Ruppert, A. S., Xue, L., Li, D. H., Steggerda, S. M. and Versele, M., et al. 2014. Resistance mechanisms for the bruton's tyrosine kinase inhibitor ibrutinib. N. Engl. J. Med. 370, 2286-2294.
DOI
|
39 |
Yang, Y. R., Follo, M. Y., Cocco, L. and Suh, P. G. 2013. The physiological roles of primary phospholipase c. Adv. Biol. Regul. 53, 232-241.
DOI
|
40 |
Yang, Y. R., Jung, J. H., Kim, S. J., Hamada, K., Suzuki, A., Kim, H. J., Lee, J. H., Kwon, O. B., Lee, Y. K. and Kim, J., et al. 2017. Forebrain-specific ablation of phospholipase cgamma1 causes manic-like behavior. Mol. Psychiatry 22, 1473-1482.
DOI
|
41 |
Kemp, P., Hubscher, G. and Hawthorne, J. N. 1961. Phosphoinositides. 3. Enzymic hydrolysis of inositol-containing phospholipids. Biochem. J. 79, 193-200.
DOI
|
42 |
Jang, H. J., Suh, P. G., Lee, Y. J., Shin, K. J., Cocco, L. and Chae, Y. C. 2018. Plcgamma1: Potential arbitrator of cancer progression. Adv. Biol. Regul. 67, 179-189.
DOI
|
43 |
Ji, Q. S., Winnier, G. E., Niswender, K. D., Horstman, D., Wisdom, R., Magnuson, M. A. and Carpenter, G. 1997. Essential role of the tyrosine kinase substrate phospholipase c-gamma1 in mammalian growth and development. Proc. Natl. Acad. Sci. USA. 94, 2999-3003.
DOI
|
44 |
Kang, D. S., Yang, Y. R., Lee, C., Park, B., Park, K. I., Seo, J. K., Seo, Y. K., Cho, H., Lucio, C. and Suh, P. G. 2018. Netrin-1/dcc-mediated plcgamma1 activation is required for axon guidance and brain structure development. EMBO Rep. 19.
|
45 |
Magno, L., Lessard, C. B., Martins, M., Lang, V., Cruz, P., Asi, Y., Katan, M., Bilsland, J., Lashley, T. and Chakrabarty, P., et al. 2019. Alzheimer's disease phospholipase c-gamma-2 (plcg2) protective variant is a functional hypermorph. Alzheimers Res. Ther. 11, 16.
DOI
|
46 |
Kertesz, Z., Gyori, D., Kormendi, S., Fekete, T., Kis-Toth, K., Jakus, Z., Schett, G., Rajnavolgyi, E., Dobo-Nagy, C. and Mocsai, A. 2012. Phospholipase cgamma2 is required for basal but not oestrogen deficiency-induced bone resorption. Eur. J. Clin. Invest. 42, 49-60.
DOI
|
47 |
Kim, H. Y., Yang, Y. R., Hwang, H., Lee, H. E., Jang, H. J., Kim, J., Yang, E., Kim, H., Rhim, H. and Suh, P. G., et al. 2019. Deletion of plcgamma1 in gabaergic neurons increases seizure susceptibility in aged mice. Sci. Rep. 9, 17761.
DOI
|
48 |
Liao, H. J., Kume, T., Mckay, C., Xu, M. J., Ihle, J. N. and Carpenter, G. 2002. Absence of erythrogenesis and vasculogenesis in plcg1-deficient mice. J. Biol. Chem. 277, 9335-9341.
DOI
|
49 |
Liu, Y., Bunney, T. D., Khosa, S., Mace, K., Beckenbauer, K., Askwith, T., Maslen, S., Stubbs, C., De Oliveira, T. M. and Sader, K., et al. 2020. Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase c gamma enzymes. EBioMedicine 51, 102607.
DOI
|
50 |
Lovlie, R., Berle, J. O., Stordal, E. and Steen, V. M. 2001. The phospholipase c-gamma1 gene (plcg1) and lithium-responsive bipolar disorder: Re-examination of an intronic dinucleotide repeat polymorphism. Psychiatr. Genet. 11, 41-43.
DOI
|
51 |
Manso, R., Rodriguez-Pinilla, S. M., Gonzalez-Rincon, J., Gomez, S., Monsalvo, S., Llamas, P., Rojo, F., Perez-Callejo, D., Cereceda, L. and Limeres, M. A., et al. 2015. Recurrent presence of the plcg1 s345f mutation in nodal peripheral t-cell lymphomas. Haematologica 100, e25-27.
DOI
|
52 |
Ombrello, M. J., Remmers, E. F., Sun, G., Freeman, A. F., Datta, S., Torabi-Parizi, P., Subramanian, N., Bunney, T. D., Baxendale, R. W. and Martins, M. S., et al. 2012. Cold urticaria, immunodeficiency, and autoimmunity related to plcg2 deletions. N. Engl. J. Med. 366, 330-338.
DOI
|
53 |
Martin-Nalda, A., Fortuny, C., Rey, L., Bunney, T. D., Alsina, L., Esteve-Sole, A., Bull, D., Anton, M. C., Basagana, M. and Casals, F., et al. 2020. Severe autoinflammatory manifestations and antibody deficiency due to novel hypermorphic plcg2 mutations. J. Clin. Immunol. 40, 987-1000.
DOI
|
54 |
Moran-Villasenor, E., Saez-De-Ocariz, M., Torrelo, A., Arostegui, J. I., Yamazaki-Nakashimada, M. A., Alcantara-Ortigoza, M. A., Gonzalez-Del-Angel, A., Velazquez-Aragon, J. A., Lopez-Herrera, G. and Berron-Ruiz, L., et al. 2019. Expanding the clinical features of autoinflammation and phospholipase cgamma2-associated antibody deficiency and immune dysregulation by description of a novel patient. J. Eur. Acad. Dermatol. Venereol. 33, 2334-2339.
DOI
|
55 |
Neves, J. F., Doffinger, R., Barcena-Morales, G., Martins, C., Papapietro, O., Plagnol, V., Curtis, J., Martins, M., Kumararatne, D. and Cordeiro, A. I., et al. 2018. Novel plcg2 mutation in a patient with aplaid and cutis laxa. Front. Immunol. 9, 2863.
DOI
|
56 |
Parker, L., Bahat, H., Appel, M. Y., Baum, D. V., Forer, R., Pillar, N., Goldberg, M. and Goldman, M. 2019. Phospholipase c-gamma 2 activity in familial steroid-sensitive nephrotic syndrome. Pediatr. Res. 85, 719-723.
DOI
|
57 |
Paterson, H. F., Savopoulos, J. W., Perisic, O., Cheung, R., Ellis, M. V., Williams, R. L. and Katan, M. 1995. Phospholipase c delta 1 requires a pleckstrin homology domain for interaction with the plasma membrane. Biochem. J. 312(Pt 3), 661-666.
DOI
|
58 |
Piechulek, T., Rehlen, T., Walliser, C., Vatter, P., Moepps, B. and Gierschik, P. 2005. Isozyme-specific stimulation of phospholipase c-gamma2 by rac gtpases. J. Biol. Chem. 280, 38923-38931.
DOI
|